UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Dong-A ST, Dongwha Pharm lose status of innovative drugmaker
Dong-A ST and Dongwha Pharm failed to renew the state-designated certificat...
by Jeong Sae-im
|
2019-07-05 16:00
라인
Lilly aims to reshape Korea’s breast cancer treatment market
Lilly Korea is seeking to reshape Korea’s breast cancer treatment market on...
by Lee Han-soo
|
2019-07-05 16:00
라인
‘Truvada will improve Korea's HIV treatment environment’
Gilead Science is strengthening its position in the local human immunodefic...
by Lee Han-soo
|
2019-07-04 10:53
라인
Janssen nixes deal with Hanmi over antidiabetic obesity drug
Janssen, a subsidiary of Johnson & Johnson, has decided to return the devel...
by Jeong Sae-im
|
2019-07-04 10:52
라인
Bukwang, UK university to co-develop Parkinson’s disease treatment
Bukwang Pharmaceutical has signed a multibillion-won contract with Universi...
by Lee Han-soo
|
2019-07-03 15:03
라인
Handok releases Fabry disease treatment
Handok said Tuesday that it has rolled out Galafold, a Fabry disease treatm...
by Lee Han-soo
|
2019-07-02 16:19
라인
26 new drugs approved in H1
Twenty-six new pharmaceutical products received approval in Korea in the fi...
by Lee Hye-seon
|
2019-07-02 14:31
라인
[News Focus]Yuhan pulled off $3.1 billion licensing deals in one year. How?
Yuhan Corp. recently made headlines by signing an $870 million licensing de...
by Jeong Sae-im
|
2019-07-02 12:11
라인
Huons launches new osteoarthritis treatment
Huons said that it has launched “Hi Hyal Once,” an osteoarthritis treatment...
by Lee Han-soo
|
2019-07-01 15:13
라인
Eli Lilly Korea gains further reimbursement for psoriasis treatment Taltz
The Korean branch of Eli Lilly said that it had gained additional reimburse...
by Lee Han-soo
|
2019-07-01 14:27
라인
BMS Korea files administrative suit to appeal Eliquis price cut
The price reduction of BMS Korea Pharmaceutical’s blood thinner Elidquis ha...
by Kim Yun-mi
|
2019-07-01 14:16
라인
Yuhan signs $870 million licensing deal with Boehringer Ingelheim
Yuhan announced a joint development and licensing agreement with Boehringer...
by Lee Han-soo
|
2019-07-01 14:09
라인
'Proteogenomics will improve ability to prevent, diagnose and treat cancer at molecular level'
With recent advancements in sequencing technologies, scientists are no long...
by Lee Han-soo
|
2019-06-28 17:43
라인
Lilly anticipates Trulicity’s growth as GLP-1 receptor antagonists get popular
As physicians have increasingly recommended glucagon-like peptide-1 (GLP-1)...
by Kim Yun-mi
|
2019-06-28 16:12
라인
Samsung Bioepis readies phase-3 trial on Soliris biosimilar
Samsung Bioepis is speeding up to develop a biosimilar of Soliris (eculizum...
by Lee Hye-seon
|
2019-06-27 17:14
라인
Eutilex unveils immunotherapy development strategy
Eutilex presented its immunotherapy development strategy during the "Global...
by Lee Han-soo
|
2019-06-27 16:51
라인
Voluntary nullifications of drug license tripled in H1
An increasing number of pharmaceutical companies voluntarily canceled the l...
by Lee Hye-seon
|
2019-06-26 14:25
라인
Seoul Pharma to export erectile dysfunction treatment to Azerbaijan
Seoul Pharmaceuticals has signed an agreement with Loghman Pharmaceutical o...
by Lee Han-soo
|
2019-06-26 13:58
라인
Novartis’ Tasigna confirms long-term success for chronic myelogenous leukemia
Novartis has reaffirmed the long-term success of Tasigna (Ingredient: Nilot...
by Lee Han-soo
|
2019-06-26 11:39
라인
Huons Global launches new BTX in Korea
Huons Global plans to launch a new botulinum toxin (BTX) product in Korea. ...
by Lee Han-soo
|
2019-06-26 10:52
-
이전
41
42
43
44
45
46
47
48
49
50
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top